RLYB - Rallybio Corp
10.8
0.295 2.731%
Share volume: 210,346
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$10.50
0.29
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-13-2025 | 05-08-2025 | 11-06-2025 | |
| Cash flow financing | 0.000 | 5.192 M | -11.000 K | 18.000 K | 0.000 | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -5.193 M | -2.630 M | 8.649 M | -11.417 M | 876.000 K | 0.000 | |
| Net income | -19.029 M | -16.236 M | -11.466 M | -11.044 M | -9.439 M | 16.016 M | |
| Depreciation | 35.000 K | 34.000 K | 32.000 K | 30.000 K | 28.000 K | 35.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 10.264 M | 2.596 M | 22.205 M | -1.573 M | 11.081 M | 29.227 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -5.193 M | -2.630 M | 8.649 M | -11.417 M | 876.000 K | 22.677 M |